Pelthos Therapeutics PTHS
NYSE PTHS
$22.71 -0.71 (-3.03%)
As of: Sep 10, 2026 · 10:59 AM EDT

Pelthos Therapeutics (PTHS) Inventory Average (2025 - 2026)

Pelthos Therapeutics (PTHS) posted Inventory Average of $22.4 million for Q2 2026, down 4.47% on a QoQ basis from $23.5 million in Q1 2026.

Analysis

Pelthos Therapeutics (PTHS) Inventory Average (2025 - 2026) Analysis & Trends

Pelthos Therapeutics has reported Inventory Average for 2 years, with the latest figure at $22.4 million in Q2 2026.

  • On a quarterly basis, Inventory Average changed N/A year-over-year to $22.4 million in Q2 2026; TTM through Jun 2026 was $22.4 million, a N/A change from a year earlier, with the FY2026 full-year figure at $22.5 million, changed N/A from the prior year.
  • Inventory Average was $22.4 million for Q2 2026 at Pelthos Therapeutics, down from $23.5 million in the prior quarter.
  • The five-year high for Inventory Average was $23.8 million in Q4 2025, with the low at $22.4 million in Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory Avg. (Qtr)
1 Johnson & Johnson 641.22 Bn 620.47 Bn 17.26 Bn 14.86 Bn
2 AbbVie 446.22 Bn 439.65 Bn 12.70 Bn 5.09 Bn
3 Merck 357.04 Bn 349.90 Bn 12.21 Bn 6.34 Bn
4 Novartis Ag 268.38 Bn 260.69 Bn 11.24 Bn 6.25 Bn
5 Pfizer 156.32 Bn 144.62 Bn 10.94 Bn 10.31 Bn
6 Sanofi 52.23 Bn 44.85 Bn 10.79 Bn -
7 Revolution Medicines 43.18 Bn 43.18 Bn - -
8 Incyte 24.85 Bn 20.31 Bn 1.57 Bn 114.08 Mn
9 United Therapeutics 21.29 Bn 18.62 Bn 683.80 Mn 186.05 Mn
10 Pelthos Therapeutics 80.38 Mn 55.82 Mn 21.23 Mn 22.45 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 22.45 Mn
Mar 31, 2026 23.50 Mn
Dec 31, 2025 23.84 Mn